The Effect of Rosuvastatin in Diabetic Polyneuropathy: A Phase IIa Randomized Double-blind Placebo-controlled Study

NCT01622777 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Polyneuropathy

Interventions

DRUG: Rosuvastatin
DRUG: Placebo

Sponsor

Alejandra Guillermina Miranda Diaz